AI Infrastructure in Indian Healthcare: Bain & HealthQuad Spotlight Tech‑Driven Transformation

Indian healthcare providers are moving AI from pilots to practice, with varying adoption across administrative and clinical workflows: Bain & Company and HealthQuad

Operational use cases are scaling first, easing administrative load on clinicians; connected clinical care, gated by today’s ~35% EMR adoption, is the larger opportunity ahead

Bain & Company and HealthQuad launched their joint report ‘AI in Indian Healthcare Delivery’ today. The report finds that artificial intelligence (AI) capabilities have advanced rapidly in recent years, and India’s healthcare infrastructure is well-positioned to accelerate adoption compared with earlier waves of digital technologies. Government initiatives, rising EMR penetration, deployment of private capital, a thriving start-up ecosystem and clinician acceptance are strengthening the enabling environment. Adoption in hospitals, however, remains nascent and uneven. The majority of providers are still running AI pilots, with meaningful scale limited to operational use cases, and only a handful of providers are expanding into more clinical applications.

This gap, in tandem with a step-change in AI’s technological capabilities, particularly in healthcare, opens up previously unchartered territories for exponential growth. Newer generative and agentic systems can increasingly execute multistep workflows with limited supervision, while the amount of expert-level work AI can complete autonomously has been doubling every six to nine months since 2023. For providers, this creates an opportunity to reduce the administrative burden on doctors, nurses, and other healthcare professionals, giving them more time to focus on patient care and higher-value clinical work.

Today, however, most providers are testing AI in controlled settings rather than deploying at scale. Early adoption is translating first into operational and workflow applications where implementation is relatively easier, and benefits can be measured more quickly. Clinical AI adoption is emerging primarily among more mature providers, though the focus remains on support tools rather than autonomous decision-making. The velocity of change in AI technology currently exceeds that of most healthcare organizations. As hospitals build the data foundations and digital infrastructure needed to scale, AI adoption in the provider space is poised to accelerate and the gap between early movers and the rest will widen quickly.

Dhruv Sukhrani

Dhruv Sukhrani, Head of Bain & Company’s Healthcare & Life Sciences practice in India, said, “AI adoption in Indian healthcare is still early, but the conditions for it to scale are strengthening quickly. The technology itself has advanced significantly; the harder question now is how providers redesign workflows, manage change and build trust among doctors and nurses. This is increasingly a business transformation challenge, not simply a technology challenge. Providers will need to focus on the highest-value use cases, build the data and organisational capabilities to scale them, and embed AI into clinical workflows with the right governance and human oversight. The next phase of adoption will be shaped by providers’ ability to bring value, deployability and trust together—not simply by access to more advanced AI models.”

As AI capabilities advance rapidly, India is strengthening the foundations needed for adoption, with tangible progress beginning to emerge. Frontier models now match or outperform pre-licensed medical professionals in some controlled clinical reasoning tests. At the same time, these capabilities are becoming more accessible: the cost of frontier AI models has fallen by approximately 92% since 2023. India, meanwhile, has made progress in building the foundations AI needs.

Three enablers will determine how quickly these foundations translate into healthcare AI at scale:

• Data readiness: EMR adoption in India at ~35% remains well below the US and UK and is concentrated among larger urban hospital chains, while most small- and mid-sized hospitals continue to rely heavily on paper records.
• Regulatory clarity: India’s framework for adaptive and autonomous clinical AI is still evolving, particularly around accountability, data governance and clinical validation.
• Locally applied talent: India has deep AI capabilities, but much of that talent is currently directed toward global markets. Indian start-ups are already building across the patient journey: pre-visit and access, diagnostics and inpatient treatment, and post discharge care.

Namit Chugh

Namit Chugh, Director – HealthQuad said: “Healthcare in India has always been constrained by scarcity of clinicians leading to enormous variation in access and outcomes. AI can potentially change that equation by being not just an efficiency lever, but a capacity multiplier. AI capabilities are advancing exponentially, with performance increasingly matching or exceeding medical experts across selected tasks. The report brings a clinician-first lens across the patient journey, which is closely aligned with the investment thesis of HealthQuad’s Fund III, which is focused on backing healthcare innovators using technology and AI to address critical gaps across care delivery. The fund's recent investment in LifeSigns, an AI-powered remote patient monitoring platform, is an example of this thesis in action.”

The next opportunity is to move from operational gains to more connected patient care.
As AI moves deeper into clinical workflows, integration, data readiness, and trust become more significant constraints, with providers typically requiring human oversight. Looking ahead, the report identifies significant headroom in a few areas:

• Remote patient monitoring
• Operating theatre and ICU optimization
• Post-discharge chronic disease management

For hospitals, capturing value from AI means treating it as a business transformation, not an IT project. This requires anchoring AI to clinically owned outcomes, sequencing adoption carefully, building both specialist AI capability and broad organizational fluency, and governing clinical AI on an ongoing basis rather than through a one-time sign-off.
For founders, building durable healthcare AI companies will require solving real clinical problems and earning trust to scale. The most important steps:

• Validate the problem in clinical settings before building
• Land with a focused solution before expanding into a platform
• Treat workflow integration as core to the product, not an afterthought
• Build validation, explainability, and patient safety in from the outset

Ultimately, scaling AI in Indian healthcare will depend on bringing value, deployability and trust together, while building the data, workflow and clinical foundations required for adoption.

Methodology

This report is based on primary interviews with CIOs and CTOs of leading hospitals and diagnostic labs and start-up founders, as well as secondary market research and a range of industry participant interviews.

About Bain & Company

Bain & Company works with leaders worldwide to solve their toughest challenges and deliver enduring results. Since 1973, we’ve partnered with clients, including private equity and portfolio companies, to build the capabilities they need to stay ahead of change and help them redefine their industries. We measure our success by our clients’ success, and we proudly hold the highest levels of client advocacy in our field.
Bain is consistently recognized globally as one of the best places to work. We operate as one global team, uniting strategists, industry and functional experts, technologists, and advisors with a vibrant ecosystem of technology partners.
Note to Editors
Bain & Company was founded in 1973 and today has 19,000 employees across 67 cities in 40 countries. We have worked with more than two-thirds of the Global 500 and more than 9,000 companies worldwide. Bain has pledged to deliver $2 billion in pro bono consulting to nonprofit, public-sector and charitable organizations by 2035. The firm is consistently recognized as a Leader in major analyst rankings across multiple areas, including digital business, innovation, strategy, experience design, customer experience, and carbon-zero transformation.

About HealthQuad

HealthQuad is one of India’s leading investment platforms focused on new-age healthcare models, and is currently investing from HealthQuad Fund III, continuing the strategy and track record established across Funds I and II. Founded in 2016, HealthQuad currently has an AUM of over US$500 million, and acts as the early-growth investment arm of Quadria Group, one of Asia’s leading dedicated healthcare investment platforms. HealthQuad backs exceptional founders building category-defining companies across HealthTech, MedTech, Bio/PharmaTech and novel care delivery, leveraging deep sector expertise, operating capabilities, and Quadria’s extensive healthcare ecosystem to scale in India and globally.

Quadria‑backed HealthQuad Secures ₹550 Cr Ist Close for Fund III, Launches with Lifesigns to Scale AI‑driven Healthcare Innovations

Quadria Group (“Quadria”) backed HealthQuad, India's leading early-growth healthcare investor - today announced first close commitments of INR 550 crores for HealthQuad Fund III, at more than one-third of the target fund size of INR 1700 crores. The contributors include existing LPs in prior funds, alongside new LPs spanning local and global fund of funds, institutions and family offices. The Fund has committed its first investment in Lifesigns, India’s leading AI powered remote patient monitoring platform and is actively pursuing other proprietary opportunities to build early portfolio visibility.

Fund III, a successor to HealthQuad Fund I and Fund II, is managed by HealthQuad Advisors Private Limited, a vehicle 100% owned by Quadria Group, through Dr Amit Varma, Abrar Mir and Sunil Thakur. Following a mutual separation with KOIS in 2025, Quadria group has retained majority of the team that continues to manage the prior funds, Fund I and II. It has further expanded the leadership with the joining of Rahul Agarwal and Namit Chugh.

Incubated in 2016, HealthQuad has been a pioneering initiative by the Quadria Group to create a distinct investment vehicle, focused on backing founders building scalable, technology-enabled and next generation healthcare businesses. Funds I and II backed over 18 companies including GoApptiv, Qure.ai, Redcliffe Labs, Cureskin, Strand Life Sciences, Medikabazaar, THB, Wysa, Ekincare, and many of which have gone on to become category leaders.

Fund III will build on HealthQuad’s proven track record of identifying and scaling early-growth stage companies, across HealthTech, MedTech, Bio/Pharma Tech and Novel Healthcare Delivery, with established commercial scale and demonstrated potential to become category-leaders in India and globally. These segments are growing 16 – 40% per annum and are collectively projected to contribute over 40% of the US$ 600 billion Indian healthcare market by 2030.

Bridging India's vast healthcare access gaps is estimated to require over 2x growth in beds, over 7x growth in clinical resources and US$ 500 billion of investment. The Fund will advance the firm's mission of partnering with exceptional founders who build scalable, new-age healthcare businesses, harnessing technology, business-model and product-led innovation to improve access, affordability and quality of care and help close these gaps.

Rahul Agarwal, Partner and IC Member, HealthQuad, said: "Healthcare is undergoing one of the most significant transformations in recent times. We believe the next decade will be defined by companies that leverage emerging technologies and AI, and innovative models to make healthcare more accessible, affordable and outcome driven. Through Fund III, we are looking to partner with exceptional founders who are building category-defining businesses with local and global relevance at scale. We thank our investors for entrusting their confidence and capital with us."

According to various estimates, over 15 lakh digital healthcare transactions take place in India every day, and over 40% clinicians now use health-tech across their workflows. The fund is positioned to capitalize on the rapid structural transformation in healthcare, driven by rising demand for preventive and continuous care, the urgency to address capacity constraints in traditional healthcare systems, and growing adoption of technology and AI. Together, these forces are enabling globally competitive healthcare innovation to emerge from India and Asia.

Sunil Thakur, Co-founder and IC Member, HealthQuad and Partner, Quadria Capital, said: "HealthQuad was created with a simple belief that healthcare requires specialist investors who understand the sector deeply and can support founders through long, arduous growth journeys. Over the past decade, we have witnessed the emergence of a new generation of healthcare entrepreneurs building world-class businesses from India and Asia. Fund III reflects our continued conviction in this opportunity and our commitment to helping founders build enduring market leaders that create meaningful impact while delivering strong outcomes for all stakeholders."

HealthQuad's differentiated approach combines deep sector specialization, proprietary sourcing and access to Quadria's extensive global healthcare ecosystem spanning providers, payors, diagnostics, pharmaceuticals, medical technology and healthcare services across Asia and beyond. This ecosystem enables portfolio companies to access strategic partnerships, growth opportunities and pathways for global scale, supported by the Group’s senior clinical and operating advisory board members.

Quadria Group-backed HealthQuad Backs LifeSigns to Scale AI-Powered Continuous Patient Monitoring

Hari Subramaniam, Founder and CEO, LifeSigns

• Partnership to strengthen LifeSigns’ integrated patient monitoring offering and accelerate company’s global expansion by leveraging HealthQuad’s global healthcare network

HealthQuad, the growth venture arm of Quadria Group focused on backing new-age healthcare models, has announced its latest investment in LifeSigns (www.lifesigns.us), India’s leading AI powered remote patient monitoring platform.

This underscores HealthQuad’s healthcare innovation led investment thesis. Healthcare must move from episodic and reactive care to continuous and predictive intelligence. . As health systems globally face rising demand in and beyond metros, workforce constraints, and cost pressures, the ability to monitor patients continuously and act early is becoming critical. LifeSigns is using AI to build a new layer of care that detects early signs of deterioration, enables timely clinical decisions, and ultimately saves lives.With deployment across tier 2 cities, an occupancy-based frugal pricing model and easy-to-scale solution, LifeSigns is driving access to high-quality healthcare where it is most needed.

For HealthQuad, this represents a high conviction investment in the next wave of healthcare innovation, where AI delivers measurable clinical impact at scale. As LifeSigns’ first institutional investor, HealthQuad brings more than just capital. Backed by Quadria’s global healthcare ecosystem, the partnership will focus on two key priorities for LifeSigns: international expansion across Southeast Asia and the GCC and strengthening its AI-led technology stack through selective integrations.

HealthQuad Fund III, a successor to HealthQuad Fund I and Fund II, aims to invest in category-defining companies of global relevance that are building bold, scalable solutions solving real-world problems.

Rahul Agarwal, Partner, HealthQuad

Rahul Agarwal, Partner, HealthQuad, said “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well positioned to help Hari and LifeSigns team to scale across global markets.”

Hari Subramaniam, Founder and CEO, LifeSigns, added “No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India. With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard.”

The global remote patient monitoring devices market stands at USD 26Bn in 2025 as health systems globally are shifting from episodic care toward continuous, decentralised monitoring.

LifeSigns has developed an integrated, US-FDA approved continuous monitoring platform that integrates a medical grade wearable, cloud dashboard, and predictive AI engine. It operates across the care continuum, from ambulances and emergency rooms to ICUs, wards, and home care.

The platform tracks key vitals including ECG, heart rate, respiration, temperature, blood pressure, and oxygen saturation. Its AI engine can detect early signs of deterioration up to 26 hours in advance and flag critical risk within a four-hour window, enabling timely intervention. Across more than 50 leading hospitals in India, LifeSigns has delivered over 87,000 life-saving alerts, reduced code blue incidents by nearly 90 percent, and lowered ICU readmissions by close to 78 percent. Its central monitoring command center enables scalable remote surveillance and helps address structural challenges.

Delhi-based Health Tech Startup Healthquad Grabs Australian Cricketer Pat Cummins as Brand Ambassador

Australian Cricketer Pat Cummins associates with Indian health-tech startup, Healthquad

Becomes Brand Ambassador and Investor

Healthquad raises approx 1Mil.$ funding from Pat and other investors

Healthquad, a unique health & fitness platform that offers 360-degree view of health statistics to its users is teaming up with Australian fast bowler and Test Captain Pat Cummins as its brand ambassador and newest Investor to make an impact in the health tech space and to offer its services to a wider consumer base across India.

Pat Cummins, known for his enviable level of fitness and health and has a long standing relationship with India having toured with the Australian side and played in the IPL for a number of seasons understands the Indian health & fitness ecosystem and is a natural fit with the startup.

Healthquad aims at transforming the Indian health industry by using proprietary algorithms which are capable of providing accurate health statistics by considering parameters like calorie-intake, daily step count, sleep patterns, water intake etc. along with other aggregated vital tracking instruments and tools to transform. The platform incentivises users to set and achieve their fitness goals by rewarding them with HQ coins which can be redeemed in multiple avenues.

 
Sanjeev Koul, Founder, Healthquad, said, “It's a privilege for us to have Pat on board as he personifies the very essence of Healthquad. It is an added advantage that Pat is familiar with the Indian health spectrum owing to his long association with the IPL. India is at the cusp of a health & fitness revolution and we’re confident that Healthquad will be leading it from the forefront.”

In describing the association, Pat Cummins said -

As an international sportsman, health and fitness are an integral part of my lifestyle. The experience of playing in the IPL has given me significant insight into the potential of the Indian health & fitness ecosystem. Anything to do with the health tech space excites me and I’m looking forward to strengthening this existing symbiotic relationship with fitness through Heathquad.

Chandra Reddy of Beyond Advisory, as transaction advisors, said, “The versatility and the horizontal nature of the Healthquad platform is an attractive proposition. It is conducive to integrating with the fast growing health tech ecosystem, including apps, wearables and other devices. We plan to scale the business in India and across other geographies. We are delighted to be associated with Pat and other consortia members for their hard work and vision to be part of this exciting journey.”

About Heathquad:

Healthquad, founded in 2019 is a comprehensive health & fitness platform. Its proprietary algorithm gives users a 360-degree view of their health by considering various parameters like calorie-intake, daily step count, sleep patterns, water intake & calorie burn, etc. to give an accurate health picture and provide the tools to transform. The app incentivises users to set and achieve their fitness goals by rewarding them with HQ coins which can be redeemed in multiple avenues. Healthquad aims to be the platform to drive & disrupt the Indian health tech industry.

Online Medical Supplies Aggregator Medikabazaar Raises $5 Mn in Funding led by HealthQuad

Mumbai-based online medical supplies aggregator Medikabazaar has raised $5 million in in the Series A round of funding led by HealthQuad, a healthcare focused venture capital fund investing in early stage healthcare companies in India.

The startup plans to use this funding to strengthen technology and increase its team size including senior leadership, according to an official statement.

Other investors who participated in this round include Elan Corporation, Sasaki Foods, CBCCo. Ltd, Kois Invest, Mitsui Sumitomo Insurance Venture Capital and its existing investors Sunil Kalra, Arun Venkatachalam & Rebright Partners II Investment Partnership.

Medikabazaar had earlier raised $1 million in pre-series A round of funding by Rebright Partners II Investment Partnership, Sunil Kalra and Arun Venkatachalam and another angel investor from Japan.

Founded in 2014 by Vivek Tiwari, who is also the present CEO of the company, Medikabazaar is an online aggregator of medical devices, medical equipment, and supplies, providing B2B services to hospitals and medical establishments.

With over 100,000 products listed its website, Medikabazaar claims to be the largest B2B online marketplace for medical equipment and medical supplies offering last mile delivery of anything under the gamut of medical equipment and consumables across 16000+ pin-codes in India.

With the infusion of fresh capital, Medikabazaar plans to to use this money to streamline its supply chain and logistics capability to reach 50,000 hospitals and clinics by the end of next financial year, as well as increase its fulfillment centres to over 20 from seven now.

“In a price sensitive healthcare environment, cost optimization and quality delivery will become critical success factors for any healthcare provider. Medikabazaar has disrupted the entire supply chain model, to directly reach hospitals and clinics across metros and smaller towns, offering competitively priced quality products in desired time-frame through its technology platform,” said HealthQuad founder Amit Varma.

Headquartered in New Delhi, VC fund HealthQuad was founded in 2016 by Amit Varma and Abrar Mir, who are also the co-founders of Singapore-based healthcare-focused private equity firm Quadria Capital. HealthQuad was spun-off from Qaudrio as its venture capital arm to capture opportunities in the healthcare sector at an early stage.

Besides Medikabazaar, HealthQuad had earlier invested in Gurgaon-based health tech firm The Healthy Billion (THB) and Bangalore-based Neurosynaptic, a turnkey telemedicine solution provider.

In healthcare and related aggregator space, Mumbai-based home healthcare services aggregator HealWell24 had raised $200,000, in May this year, from bunch of angel investors including Prashant Mehta, Mitali Pawar, Nikhil G and Bhavesh P, members of Indian Cooperative Oncology Network (ICON), and R Ranganathan.

In December last year, Kolkata-bassd healthcare services aggregator-marketplace EasyBuyHealth had raised seed funding of $350,000.

Source - Economic Times,

Healthcare Focused VC Firm Healthquad Secures Rs 750 Mn, Eye To Invest In 8-10 Companies

Healthcare focused venture capital fund, Healthquad has achieved its final close with the total commitment of Rs 750 million for investing in thematic and disruptive healthcare business models in India. The Fund is also the first early stage investment vehicle by the leading healthcare private equity investors, Dr. Amit Varma, Abrar Mir and Charles Antione Janssen.

The Fund targets to invest around Rs 4 billion in healthcare companies that have the potential to disrupt the healthcare landscape by dramatically improving the productivity, affordability and accessibility of healthcare through differentiated and innovative solutions.

Commenting on the development, fund’s sponsor Dr Amit Varma said, “Healthcare sector has seen the emergence of over 500 startups in the last two years and venture capital firms have infused around Rs. 25 billion. We are looking to deploy around Rs. 4 billion, along with co-investors and partner funds in healthcare models that are driven by new age disruptive technology and are changing the way healthcare is delivered and accessed in India.”

The Fund’s investment strategy targets five key healthcare sub-sectors including healthcare delivery services, life-sciences, medical devices and technology, healthcare IT and associated healthcare services. It is looking to invest in 8-10 companies. Prior to its final close, the Fund has already made an investment in four companies including the recently announced investment in Regency Healthcare.

“Our first four Healthquad investments have confirmed that business model innovations and health tech innovations will open access to quality healthcare for hundreds of millions of neglected Indians. Our final close will allow us to fund more, fast growing, profitable and highly impactful companies. We look forward to supporting great entrepreneurs for the benefit of patients as well as our LPs,” said Charles Antione Janssen, Fund’s third co-sponsor.

Delhi-based venture capital, Healthquad aims to support high quality entrepreneurial talent driving business models that aim to provide thematic and disruptive solution to access, affordability and quality. With the help of its high quality operating team and network, Healthquad provides a proposition of mentoring to companies to build robust business plan and supporting them in their growth strategy by providing access to its vast network of business contacts in the healthcare sector.

If we talk about the figures, the Indian healthcare sector is valued at over Rs 7 trillion and is growing at a rate of over 15% per annum making it one of the most attractive sectors for investment by the private sector. An imperative part within all this is the new age models that are unshackling the traditional forms of healthcare delivery and products including digitization of services and product innovation and disintermediation of delivery models. All these are being driven by the need to provide access, affordability and quality.

Healthtech Startup ‘Neurosynaptic’ Raises Investment from Healthquad, IAN & Axilor Ventures

With the commitment to make quality healthcare affordable to the masses, Neurosynaptic Communications has raised an undisclosed amount in Series A round of funding from healthcare focused venture fund – Healthquad, World’s largest group of angel investors – Indian Angel Network and Infosys co-founders backed – Axilor Ventures.Healthquad and IANwill be joining the board of the company.

The Company has earlier received strategic investment from e-Zest Solutions Ltd, a global digital experience engineering company, with large international organization on healthcare product innovation.

As population in both rural and urban India struggles with the challenge of access to quality healthcare, Neurosynaptic offers proven, highly scalable e-health and m-health technology solutions that bring together products, partners and processes in the healthcare delivery ecosystem.

Established in the year 2002 by Sameer SubhashSawarkar and Rajeev Kumar, Neurosynaptic aims at eliminating the health complications faced by the developing world. It enables access of quality and affordable healthcare to masses in rural and semi urban remote areas through its low cost, high quality remote access telemedicine solution. The Company achieves this through its Unique,cloud-based telemedicine platform ReMeDi® (Remote Medical Diagnostics), that provides screening, primary diagnosis and triaging capabilities by remotely connecting the different stakeholders (patients, doctors and point-of-care service providers) of healthcare delivery ecosystem and offering 35+ point of care diagnostics including Physiology, Urine and Blood Chemistry tests, and various others, along with Electronic Medical Records. The company has reached over 50 million populationtill date by deploying itsReMeDi® solution in over 2,000 villages across India.

Commenting on the announcement, Sameer SubhashSawarkar, CEO at Neurosynaptic said, “Access to basic healthcare is a daunting challenge in rural India and most of the developing world, and there is a dire need for a solution like ReMeDi® which is targeted at the rural population. We have been relentlessly working at building solutions that are most beneficial for people who have limited or no access to quality health care. Not only does ReMeDi® connect up the entire fragmented ecosystem for last-mile delivery, but it also offers several features like workflow configuration, and the latest sensor & wireless communication technologies. Our Patented Safe Devicestechnology helps curb the misuse of devices and eliminates human errors. We are looking at exciting times ahead. The soon-to-be-launched ReMeDi®-NOVA and pay-per-use model with Cloud, Mobile Technologies, UX and Analytics, shall revolutionize the last-mile healthcare access. We are delighted to have such strong support from our investors who are equally focused in bringing about large scale impact and building a Global Enterprise for social change.”

The company plans to utilize the investment for International Certificationsand launch of its products and to scale international business in Africa and South / South East Asia, besides further penetration across India. They are also in the process of launching the upgraded version of its flagship ReMeDi®platform which would offer SaaS based (pay-per-use) telemedicine and m-health solution along with a wider range of diagnostics.

“Telemedicine as a concept and solution is gaining traction world over, equally in developed and developing markets. This solution takes care of accessibility, which is a primary driver in the under developed markets and affordability, which drives the need in developed markets. Governments and insurance agencies are working towards building a conducive environment for accelerated acceptance of such solutions. We feel that Neurosynaptic, with its proprietary product and solutions offering and deep experience is best placed to capture the opportunity in this region. We will work closely with the company to help build their growth plan as they move along in expanding their network & adding the services on their platform”commented Dr. Amit Varma, Sponsor of Healthquad

Increased technological improvement, rise in the incidence and prevalence of chronic diseases along with increase in aging population has enhanced demand for remote monitoring. Global telemedicine market is expected to hit the US$ 35,500 Mn mark by 2020 at a CAGR of 15%.

Lead IAN investor Nagaraja Prakasam commented on the investment saying,“As only 2% doctors are in rural area where 68% of India lives, the medical expenses for them is triplefold– loss of wages, travel to nearby town, expenses for the person to accompany. This makes them not to seek health care until it’s in very late, thus health care expenses are one of the top reason for poor not able to come out of poverty or puts them back in poverty. Neurosynatpic with its patented ReMeDi® digital health solutions aims to improve this situation, and has successfully demonstrated scale on the ground. The team has phenomenal talent and we believe they will continue to excel in the industry to be a market leader.” Naga has led 6 other IAN investments including Uniphore, GoCoOp, Freshworld, Saahas, SP Robotics,Soloron through IAN Impact, encouraging entrepreneurs solving real problems.

“We welcome the new investors aboard. This is big endorsement of e-Zests’ strategic investment, and we look forward to the Company growing Global by leaps and bounds”, says Shrikant Shingane, a serial entrepreneur, and e-Zests’ representative on the Company’s Board.

“Of the three important healthcare outcomes of access, affordability and effectiveness, access is perhaps the first and most important problem to solve. The Neurosynaptics team is one of the few with a world-class telemedicine and point of care diagnostic solution for solving the access problem at a scale when it can make a real impact. This investment will help them expand their reach to smaller towns in India as well as replicate their model in other emerging markets.” commented Mr. SD Shibulal, Co-Founder Axilor Ventures.

The company is focused on building a telemedicine solution model & a SaaS model for hospitals, clinics, governments, NGOs across the globe. Together with its partners, Neurosynaptic'sReMeDi® solution today brings access to healthcare in 30 districts with over 2,000 village centers and over 8,000 village health operators reaching to 50 million people in India. With an aim to co-create a healthier surrounding, Neurosynaptic has demonstrated the impact of technology solutions at a large scale in tackling this global problem.